Zantac® heartburn medication linked to cancer. Were you diagnosed with cancer after taking Zantac®? You may be entitled to compensation.
Zantac® is a popular heartburn available over-the-counter at many pharmacies. It contains the chemical Nitrosodiomethylamine (NDMA).
On September 13, 2019, the FDA issued a warning that the heartburn medicine Zantac® (Ranitidine) contains the cancer-causing chemical Nitrosodimethylamine (NDMA). The FDA issued a warning after a pharmacy in Connecticut discovered elevated levels of NDMA while testing Zantac®.
It has been reported that the levels of cancer-causing NDMA are anywhere from 3,000 to 26,000 times higher than the legally allowable limit set by the FDA. Zantac® and its generic versions were pulled from shelves of Walmart, Rite Aid, CVS and Walgreens stores after the FDA announced that it had detected the cancer-causing chemical in samples of the drug.
There are medical claims that Zantac® causes high levels of NDMA exposure in users. Recent studies have confirmed that the unstable particles of the medication break down in the digestive tract to create harmful levels of NDMA. Based on these claims, significant NDMA exposure could result from taking brand name or generic Zantac® products, regardless of the manufacturer.
Users were exposed to high levels of Nitrosodimethylamine (NDMA).
Users suffered from symptoms including but not limited to liver cancer, kidney cancer, lung cancer, intestinal cancer, stomach cancer, pancreatic cancer, colon cancer, ovarian cancer, esophageal cancer, and testicular cancer.
FDA Calls For Heartburn Drug Zantac® To Be Pulled From Market Immediately
On April 1, 2020, The FDA issued an order to have Zantac® products and generics to be immediately pulled from stores across the nation. In an ongoing investigation, the FDA determined that levels of Nitrosodimethylamine (NDMA) in the heartburn medications increase over time especially when stored at higher-than-normal temperatures, pose a risk to public health.
We are 100% FREE until you win. A case review takes minutes to discuss. If you think you have a claim, sign up for a case review to see if you qualify.
Fill out the below form to the best of your ability.
A member of our team will call to discuss your case to make sure you qualify and answer any of your questions.
If you qualify, a tortx™ rep will connect you with a qualified legal partner.
This claim is not currently active.
Sign up to get live updates on the status of this claim as more information becomes available.
Information submitted by contact form is not protected by attorney-client privilege. Therefore, please don't submit private or sensitive details.
Yes. The FDA determined that levels of Nitrosodimethylamine (NDMA) in the heartburn medications increase over time and when stored at higher-than-normal temperatures which pose a risk to cancer.
Yes. On April 1, 2020, The FDA issued an order to have Zantac® products and generics to be immediately pulled from stores across the nation.
The FDA determined that levels of Nitrosodimethylamine (NDMA) in the heartburn medication Zantac® increase over time especially when stored at higher-than-normal temperatures, pose a risk to public health.
Nitrosodimethylamine (NDMA) is a cancer-causing chemical found in Zantac®.
Yes. It doesn’t matter which state you live in. If you were diagnosed with cancer after taking Zantac® you may be entitled to compensation. Contact us today to get started with your free case review.
Certain states have time limits for filing a Zantac® cancer lawsuit. However, the majority of individuals who were injured by Zantac® will fall within those time limits if they get representation in the near future.
